Inogen (INGN) Current Assets (2013 - 2026)
Inogen's (INGN) quarterly Current Assets came in at $194.1 million in Q2 2026, down 4.42% year-over-year from $203.1 million in Q2 2025, and up 1.82% quarter-over-quarter from $190.7 million in Q1 2026.
Analysis
Inogen (INGN) Current Assets (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Current Assets for 14 consecutive years, with $194.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Assets fell 4.42% year-over-year to $194.1 million in Q2 2026; TTM through Jun 2026 was $194.1 million, a 4.42% decrease from a year earlier, with the FY2025 full-year figure at $198.3 million, up 6.93% from the prior year.
- Current Assets was $194.1 million for Q2 2026 at Inogen, up from $190.7 million in the prior quarter.
- Over five years, Current Assets peaked at $318.1 million in Q1 2022 and troughed at $185.5 million in Q4 2024.
- A 5-year average of $233.5 million and a median of $203.4 million in 2025 frame the typical range for Current Assets.
- Across the five-year window, Current Assets tumbled 32.03% in 2023 and climbed 6.93% in 2025, its largest moves.
- Over 5 years, Current Assets stood at $304.6 million in 2022, then sank by 32.03% to $207.1 million in 2023, then declined by 10.44% to $185.5 million in 2024, then rose by 6.93% to $198.3 million in 2025, then fell by 2.1% to $194.1 million in 2026.
- The last three Current Assets figures came in at $194.1 million (Q2 2026), $190.7 million (Q1 2026), and $198.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 9.54 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 24.39 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 14.42 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 7.97 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 6.82 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 6.62 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 4.09 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn | 194.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 194.14 Mn |
| Mar 31, 2026 | 190.67 Mn |
| Dec 31, 2025 | 198.30 Mn |
| Sep 30, 2025 | 203.72 Mn |
| Jun 30, 2025 | 203.12 Mn |
| Mar 31, 2025 | 200.71 Mn |
| Dec 31, 2024 | 185.45 Mn |
| Sep 30, 2024 | 192.55 Mn |
| Jun 30, 2024 | 194.79 Mn |
| Mar 31, 2024 | 199.19 Mn |
| Dec 31, 2023 | 207.07 Mn |
| Sep 30, 2023 | 225.27 Mn |
| Jun 30, 2023 | 269.22 Mn |
| Mar 31, 2023 | 283.15 Mn |
| Dec 31, 2022 | 304.65 Mn |
| Sep 30, 2022 | 317.78 Mn |
| Jun 30, 2022 | 315.45 Mn |
| Mar 31, 2022 | 318.12 Mn |
| Dec 31, 2021 | 329.19 Mn |
| Sep 30, 2021 | 335.83 Mn |